Email updates

Keep up to date with the latest news and content from Cancer Cell International and BioMed Central.

Open Access Open Badges Correction

Correction: MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer

Jia Li, Xiangjie Kong, Junfeng Zhang, Qifeng Luo, Xiaoyu Li and Lin Fang*

Author Affiliations

Department of Breast and Thyroid, Shanghai Tenth People’s Hospital, Shanghai, 200072, China

For all author emails, please log on.

Cancer Cell International 2013, 13:17  doi:10.1186/1475-2867-13-17

The electronic version of this article is the complete one and can be found online at:

Received:20 February 2013
Accepted:20 February 2013
Published:21 February 2013

© 2013 Li et al.; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


After publication of this article [1], the authors noted an error in Figure http://1 webcite. The labelling of normal tissues and cancer tissues was inverted. Please see Figure 1 for the corrected version. The authors apologise for any inconvenience this has caused.

thumbnailFigure 1. miR-26b is relatively downregulated in breast cancer.


  1. Li J, Kong X, Zhang J, Luo Q, Li X, Fang L: MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer.

    Cancer Cell Int 2013, 13:7. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text OpenURL